| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.26 | 3e-13 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.26 | 9e-13 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.26 | 4e-12 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-11 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-10 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-10 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-09 |